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LETTER TO THE EDITOR
Diagnosing options in patient with sarcopenia
Dear Editor
We read the article ‘Are sarcopenia, obesity and sarcopenic
obesity predictive of outcome in patients with colorectal liver
metastases?’ written by Lodewick et al. 1 with great interest.
They aimed to investigate the influence of sarcopenia, obes-
ity and sarcopenic obesity on morbidity, disease-free and over-
all survival after a partial liver resection for colorectal liver
metastases (CRML). In the present study, sarcopenia was eval-
uated by computerized tomography (CT) within 3 months
before liver surgery.1 They concluded that sarcopenia, obesity
and sarcopenic obesity did not worsen disease-free and overall
survival and complication rates after a partial liver resection
for CRLM. Thank to the authors for their contribution.
We would like to comment on some methodological
issues in this study. Computed tomography and magnetic
resonance imaging are two well-known diagnosing options to
measure muscle mass. The European Working Group on
Sarcopenia in Older People (EWGSOP) reached a consensus
on diagnostic criteria for age-related sarcopenia a few years
ago.2 In this consensus, validation of a single slice CT to
define muscle mass was assessed only by comparing with
Dual-energy X-ray absorptiometry (DEXA) which is also rec-
ommended as a non-gold standard technique.2 Therefore,
the accuracy of single-slice CT image analysis to determine
body composition may be limited because of the internal
errors of the DEXA method.3 Additionally, muscle strength
and function are the other important components of sarco-
penia.4 It would be better if the authors gave information
about these factors. As a conclusion, sarcopenia should be
assessed with the appropriate technical and assessing labora-
tory and clinical findings together. By this means, the study
will be more precious.
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